Man Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-38,524
Closed -$553K 2364
2025
Q2
$553K Buy
+38,524
New +$528K ﹤0.01% 1799
2022
Q1
Sell
-52,583
Closed -$1.43M 2283
2021
Q4
$1.43M Sell
52,583
-12,865
-20% -$344K ﹤0.01% 1253
2021
Q3
$1.86M Sell
65,448
-5,562
-8% -$169K 0.01% 1193
2021
Q2
$2.14M Buy
71,010
+4,801
+7% +$142K 0.01% 1205
2021
Q1
$1.69M Buy
+66,209
New +$1.7M 0.01% 1160
2020
Q1
Sell
-347,877
Closed -$9.67M 1763
2019
Q4
$9.67M Sell
347,877
-83,913
-19% -$2.1M 0.03% 702
2019
Q3
$9.77M Buy
431,790
+213,629
+98% +$4.87M 0.04% 599
2019
Q2
$5.5M Buy
218,161
+126,987
+139% +$3.41M 0.02% 909
2019
Q1
$2.48M Sell
91,174
-97,091
-52% -$3.26M 0.01% 1236
2018
Q4
$6.21M Sell
188,265
-340,492
-64% -$13.7M 0.03% 658
2018
Q3
$24.7M Buy
528,757
+194,334
+58% +$8.92M 0.09% 248
2018
Q2
$14.5M Buy
334,423
+184,748
+123% +$8.85M 0.06% 399
2018
Q1
$8.33M Buy
+149,675
New +$8.2M 0.04% 578

Other funds holding MD

Man Group's MD Position: Q3 2025 in Review

Man Group sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 38,524 shares — an estimated $553K sold.

Man Group first reported a position in MD in Q1 2018 and held it in 13 quarters. The position peaked at $24.7M in Q3 2018. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

  • Man Group reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 38,524 Pediatrix Medical shares in Q3 2025, an estimated $553K.
  • Man Group first reported a position in Pediatrix Medical in Q1 2018 and held it in 13 quarters.
  • Man Group's Pediatrix Medical position peaked at $24.7M in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.